Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Allogeneic bone marrow derived clonal mesenchymal stromal cells in refractory rheumatoid arthritis: a pilot study.
Jamshidi A, Beheshti Maal A, Alikhani M, Madani H, Sadri B, Moghaddassi M, Salimzadeh A, Ahmadipour M, Shahrbaf MA, Hajizadeh-Saffar E, Baghaban Eslaminejad M, Hassani SN, Taghiyar L, Abbasi F, Baharvand H, Vosough M. Jamshidi A, et al. Among authors: sadri b. Regen Med. 2024 Dec;19(12):599-609. doi: 10.1080/17460751.2024.2443352. Epub 2024 Dec 23. Regen Med. 2024. PMID: 39713986 Clinical Trial.
Safety evaluation of bi-layered allogenic keratinocyte and fibroblast skin substitute for diabetic foot ulcers-SAFESKIN-DFU: A Phase 1 clinical trial.
Farzanbakhsh S, Amini MR, Madani H, Sadri B, Hassani SN, Fallah N, Samadian A, Aghdami R, Khalajasadi Z, Baharvand H, Vosough M, Hajizadeh-Saffar E. Farzanbakhsh S, et al. Among authors: sadri b. Diabetes Obes Metab. 2024 Nov;26(11):5078-5086. doi: 10.1111/dom.15843. Epub 2024 Aug 19. Diabetes Obes Metab. 2024. PMID: 39161059 Clinical Trial.
A single-center, open-labeled, randomized, 6-month, parallel-group study to assess the safety and efficacy of allogeneic cultured keratinocyte sheet transplantation for deep second-degree burn wounds: rationale and design of phase I/II clinical trial.
Farzanbakhsh S, Shahrbaf MA, Madani H, Dahmardei M, Sadri B, Vosough M. Farzanbakhsh S, et al. Among authors: sadri b. Trials. 2024 Apr 1;25(1):226. doi: 10.1186/s13063-024-08070-4. Trials. 2024. PMID: 38556879 Free PMC article. Clinical Trial.
Advanced Therapeutic Medicinal Products in Bone and Cartilage Defects.
Diaz-Solano D, Sadri B, Peshkova M, Shpichka A, Smirnova O, Shams R, Timashev P, Vosough M. Diaz-Solano D, et al. Among authors: sadri b. Curr Rev Clin Exp Pharmacol. 2024;19(4):355-369. doi: 10.2174/0127724328274436231207062008. Curr Rev Clin Exp Pharmacol. 2024. PMID: 38275042 Review.
31 results